Literature DB >> 29482870

Radiation Dose-Volume Effects for Liver SBRT.

Moyed Miften1, Yevgeniy Vinogradskiy2, Vitali Moiseenko3, Jimm Grimm4, Ellen Yorke5, Andrew Jackson5, Wolfgang A Tomé6, Randall K Ten Haken7, Nitin Ohri6, Alejandra Méndez Romero8, Karyn A Goodman2, Lawrence B Marks9, Brian Kavanagh2, Laura A Dawson10.   

Abstract

Stereotactic body radiation therapy (SBRT) has emerged as an effective, noninvasive treatment option for primary liver cancer and metastatic disease occurring in the liver. Although SBRT can be highly effective for establishing local control in hepatic malignancies, a tradeoff exists between tumor control and normal tissue complications. The objective of the present study was to review the normal tissue dose-volume effects for SBRT-induced liver and gastrointestinal toxicities and derive normal tissue complication probability models.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2018        PMID： 29482870      PMCID： PMC6095822          DOI： 10.1016/j.ijrobp.2017.12.290

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


  18 in total

1.  Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation.

Authors:  Jennifer Pursley; Issam El Naqa; Nina N Sanford; Bridget Noe; Jennifer Y Wo; Christine E Eyler; Matthew Hwang; Kristy K Brock; Beow Y Yeap; John A Wolfgang; Theodore S Hong; Clemens Grassberger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-04-27       Impact factor: 7.038

2.  Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design.

Authors:  Vitali Moiseenko; Jimm Grimm; Ellen Yorke; Andrew Jackson; Anthony Yip; Minh-Phuong Huynh-Le; Anand Mahadevan; Kenneth Forster; Michael T Milano; Jona A Hattangadi-Gluth
Journal:  Cureus       Date:  2020-10-05

3.  Objective assessment of the effects of tumor motion in radiation therapy.

Authors:  Yijun Ding; Harrison H Barrett; Matthew A Kupinski; Yevgeniy Vinogradskiy; Moyed Miften; Bernard L Jones
Journal:  Med Phys       Date:  2019-06-07       Impact factor: 4.071

4.  Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [18F]FDGal PET/CT.

Authors:  Michael Sørensen; Mette Marie Fode; Jørgen Baltzer Petersen; Marianne Ingerslev Holt; Morten Høyer
Journal:  Radiat Oncol       Date:  2021-10-01       Impact factor: 3.481

Review 5.  Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity.

Authors:  Shirley Lewis; Laura Dawson; Aisling Barry; Teodor Stanescu; Issa Mohamad; Ali Hosni
Journal:  JHEP Rep       Date:  2022-05-14

6.  Repeated SBRT for in- and out-of-field recurrences in the liver.

Authors:  Eleni Gkika; Iosif Strouthos; Simon Kirste; Sonja Adebahr; Michael Schultheiss; Dominik Bettinger; Ralph Fritsch; Volker Brass; Lars Maruschke; Hannes Philipp Neeff; Sven Arke Lang; Ursula Nestle; Anca-Ligia Grosu; Thomas Baptist Brunner
Journal:  Strahlenther Onkol       Date:  2018-10-23       Impact factor: 3.621

7.  Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity.

Authors:  Matthew M Cousins; Theresa P Devasia; Christopher M Maurino; Justin Mikell; Matthew J Schipper; Ravi K Kaza; Theodore S Lawrence; Kyle C Cuneo; Yuni K Dewaraja
Journal:  J Nucl Med       Date:  2021-09-09       Impact factor: 11.082

8.  High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview.

Authors:  Jimm Grimm; Lawrence B Marks; Andrew Jackson; Brian D Kavanagh; Jinyu Xue; Ellen Yorke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-05-01       Impact factor: 8.013

9.  A single-institutional experience with low dose stereotactic body radiation therapy for liver metastases.

Authors:  Roman O Kowalchuk; Michael R Waters; K Martin Richardson; Kelly M Spencer; James M Larner; C R Kersh
Journal:  Rep Pract Oncol Radiother       Date:  2020-10-02

10.  Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes.

Authors:  Fabian Weykamp; Philipp Hoegen; Sebastian Klüter; C Katharina Spindeldreier; Laila König; Katharina Seidensaal; Sebastian Regnery; Jakob Liermann; Carolin Rippke; Stefan A Koerber; Carolin Buchele; Jürgen Debus; Juliane Hörner-Rieber
Journal:  Front Oncol       Date:  2021-06-09       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.